Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT06510374 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE3 |
| Target Enrollment | 454 participants |
| Active Locations | 54 sites in the US |
| Sponsor | Ferring Pharmaceuticals |
| Last Updated on CT.gov | October 16, 2026 (5 days ago) |
As of October 21, 2026: Clinical trial NCT06510374 is currently recruiting participants. This phase3 study for bladder cancer is actively seeking new participants at 54 locations across the United States. The study is sponsored by Ferring Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06510374 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 54 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06510374 was last updated 5 days ago (October 16, 2026). HelloStudys verifies this status automatically.